Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

International Study on Age-related disparity in Cancer patient survival

Projektbeschreibung

Krebs: Welche Rolle spielt das Alter beim Behandlungserfolg?

Millionen Menschen erhalten jedes Jahr eine Krebsdiagnose. Ältere Erwachsene bilden dabei die größte Gruppe und ihre Zahl wird sich in Zukunft wohl sogar noch verdoppeln. Ältere Krebserkrankte profitieren nicht im gleichen Maße von neuen Entwicklungen in Diagnostik und Therapie wie Betroffene mittleren Alters. Dieses Missverhältnis hat immense Auswirkungen auf ihr Leben. Das EU-finanzierte Projekt ISAC wird daher die Rolle von Komorbiditäten und anderen Faktoren untersuchen, die zu unterschiedlichen Überlebensraten bei älteren und jüngeren Erkrankten führen. Aus den Projektergebnissen werden sich Maßnahmen ableiten lassen, die die Überlebenswahrscheinlichkeit unabhängig vom Alter erhöhen.

Ziel

Cancer patients are increasingly surviving their disease, but disparities in cancer outcomes still persist, and even widen, for some groups of patients. This is the case for older adults as they have not benefitted from the improvements in cancer diagnosis and treatment at the same magnitude as their middle-aged counterparts. Older adults account for the largest proportion of cancer diagnoses, and with the number of diagnoses expected to double in two decades such disparities will result in substantial amount of years of life lost due to unfair age-related disparities in cancer survival. The ISAC project thus aims to investigate the role of comorbidities and other factors in cancer survival disparities among older patients compared with younger patients, which will aid interventions to increase the probability of survival regardless of age. Dr Sophie Pilleron will have the opportunity to be trained at the highest possible level, extending her knowledge in comorbidities and health disparities research in the University of Otago, and her knowledge in colon and lung cancer in the THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD. She will also extend her transferable skills (e.g. grant writing, oral communication, and student supervision), which are necessary for a successful career as an independent researcher. Finally, the results of the ISAC project will be disseminated and communicated to the scientific community, policy makers and the general public through a range of activities. For example, the findings of the project will be disseminated through high-impact publications and presentations at international conferences, and the Fellow will directly present her research to policy makers. She will also target non-specialists through media outlets, social networking services, online videos, or presentations at science festivals in order to facilitate the translation of the findings and their related implications to a non-scientific audience.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Finanzierungsplan

MSCA-IF-GF - Global Fellowships

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) H2020-MSCA-IF-2018

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Netto-EU-Beitrag
€ 201 275,52
Adresse
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
Vereinigtes Königreich
Region
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 201 275,52

Beteiligte (1)

Partner (1)